Published 27 June 2026 • By Dr. Megan Tranter
Ethylene oxide is one of the most useful and most dangerous chemicals in modern healthcare. Roughly half of all sterile medical devices in the United States are sterilized with it, because it penetrates packaging and complex instruments at low temperature without damaging heat-sensitive materials. It is also a confirmed human carcinogen, mutagenic, and reactive enough to damage DNA directly. That tension, between an irreplaceable industrial function and a serious cancer hazard, has made ethylene oxide the subject of one of the most contentious regulatory battles in occupational and environmental health.
What You’ll Learn
- Why ethylene oxide is used for sterilization and what makes it hazardous.
- How OSHA’s standard at 29 CFR 1910.1047 regulates worker exposure.
- Why IARC classifies ethylene oxide as a Group 1 human carcinogen.
- What the EPA’s 2024 NESHAP for commercial sterilizers requires and why it is disputed.
- What recent epidemiology shows about cancer risk at low exposures.
Introduction
Ethylene oxide, abbreviated EtO or EO, is a colorless, flammable gas at room temperature with a faintly sweet odor that is not detectable at concentrations low enough to be safe. Its value in sterilization comes from its reactivity: it alkylates proteins and nucleic acids, killing microorganisms even within sealed packages and the narrow lumens of complex devices. That same alkylating chemistry is what makes it toxic to the people who use it, because the molecule reacts with human DNA just as readily as with microbial DNA. As a reactive gas, its behavior and control follow the principles covered under exposure to gases and vapors, and the limits placed on it illustrate the practical role of occupational exposure limits.
OSHA and 29 CFR 1910.1047
OSHA regulates occupational exposure to ethylene oxide under the substance-specific standard at 29 CFR 1910.1047, promulgated in the 1980s. The standard sets a permissible exposure limit of 1 part per million as an eight-hour time-weighted average, and an excursion limit of 5 parts per million averaged over fifteen minutes. It also establishes an action level of 0.5 part per million that triggers periodic exposure monitoring and medical surveillance. The standard requires engineering controls and work practices as the primary means of compliance; regulated areas; respiratory protection when controls are insufficient; hazard communication; and emergency procedures. The framework is conventional industrial hygiene, but the central scientific problem is that the 1 ppm limit was set decades ago, and the cancer risk understood today implies that compliance with the legacy limit does not guarantee a low cancer risk.
Carcinogenicity and the IARC Classification
The International Agency for Research on Cancer classifies ethylene oxide in Group 1, carcinogenic to humans. The classification rests on a coherent body of evidence: sufficient evidence of carcinogenicity in experimental animals, strong mechanistic evidence that ethylene oxide is a direct-acting mutagen and genotoxicant, and epidemiological evidence linking exposure to lymphohematopoietic malignancies and breast cancer. The mechanistic case is unusually strong. Because ethylene oxide alkylates DNA directly, it does not require metabolic activation, and as a genotoxic carcinogen, it is generally treated as having no safe threshold, meaning risk declines with dose but does not disappear at low concentrations. Studies of occupationally exposed workers, including sterilant workers, have shown chromosomal damage in lymphocytes and other cells that tracks with the level and duration of exposure, reinforcing the biological plausibility of the cancer associations.
The EPA 2024 NESHAP and the Regulatory Fight
While OSHA governs the workplace, the Environmental Protection Agency regulates ethylene oxide emissions into surrounding communities under the Clean Air Act. The EPA’s updated risk assessment concluded that ethylene oxide is substantially more potent as a carcinogen than previously assumed, which recast emissions from commercial sterilizers as a significant community cancer risk. In 2024, the EPA finalized amendments to the National Emission Standards for Hazardous Air Pollutants for ethylene oxide commercial sterilizers, designed to cut emissions from these facilities by roughly ninety percent and to bring lifetime cancer risk down toward the agency’s benchmark. The rule pairs with proposed worker-protection provisions that would lower the in-facility exposure target well below the legacy OSHA limit over a phase-in period. The regulation is genuinely contested. Industry and sterilization-dependent stakeholders have argued that the medical-device supply chain depends on these facilities and that aggressive timelines threaten device availability, and some scientists dispute the magnitude of the low-dose risk estimate. In March 2025, the EPA granted reconsideration of the 2024 rule, and in March 2026, it published a proposed reconsideration that would rescind the residual-risk standards set under Clean Air Act section 112(f)(2) and relax several compliance requirements for commercial sterilizers. As of mid-2026, EPA held a public hearing on that proposal in April 2026 and the public comment period closed in May 2026. As of mid-2026 the reconsideration has not been finalized, so the 2024 standards remain in effect for the time being. The dispute is a textbook example of the collision between precautionary public-health regulation and the realities of an essential industrial process.
Recent Epidemiology at Low Exposures
The most influential epidemiological evidence comes from a large NIOSH cohort of sterilization workers, which found increased mortality from lymphohematopoietic cancers and increased breast cancer incidence and mortality associated with high cumulative exposure. A 2019 systematic review and meta-analysis reported an elevated pooled relative risk for lymphohematopoietic cancer (meta-relative risk 1.48) but found no overall association for breast cancer (meta-relative risk 0.97), though its authors judged the most recent studies as not supporting an association. More recent work has extended the question from the workplace to the community. A 2023 study published in the Journal of the National Cancer Institute examined modeled ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a United States cohort, contributing to evidence that environmental and occupational exposures may carry risk. The scientific debate now centers less on whether ethylene oxide causes cancer, which is well established, and more on the precise shape of the dose-response relationship at the low concentrations typical of modern facilities and nearby neighborhoods. That uncertainty is exactly what drives the regulatory contention, because the estimated benefit of tighter limits depends heavily on how risk behaves at the low end of the exposure range.
Summary
Ethylene oxide presents a hard trade-off between an essential sterilization technology and a confirmed carcinogen. OSHA’s 1 ppm standard regulates the workplace but predates the current understanding of cancer risk. IARC places the gas firmly in Group 1 on strong mechanistic and epidemiological grounds, and the EPA’s 2024 NESHAP attempts to slash community emissions amid vigorous industry and scientific dispute. Recent epidemiology continues to support the lymphohematopoietic and breast cancer associations while leaving the low-dose dose-response, and therefore the right regulatory limits, genuinely uncertain.
Helpful Resources
- OSHA: Ethylene Oxide
- EPA: Hazardous Air Pollutants and Ethylene Oxide
- NIOSH: Ethylene Oxide
- Related reading: Exposure to Gases and Vapors and Occupational Exposure Limits.
Bibliography
Hogstedt, C., Aringer, L., & Gustavsson, A. (1986). Epidemiologic support for ethylene oxide as a cancer-causing agent. JAMA, 255(12), 1575-1578. https://doi.org/10.1001/jama.1986.03370120053023
International Agency for Research on Cancer. (2012). Ethylene oxide. In Chemical agents and related occupations (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100F, pp. 379-400). World Health Organization. https://publications.iarc.fr/123
Jain, R. B. (2020). Associations between observed concentrations of ethylene oxide in whole blood and smoking, exposure to environmental tobacco smoke, and cancers including breast cancer. Environmental Science and Pollution Research, 27(17), 20912-20919. https://doi.org/10.1007/s11356-020-08564-z
Jinot, J., Fritz, J. M., Vulimiri, S. V., & Keshava, N. (2018). Carcinogenicity of ethylene oxide: Key findings and scientific issues. Toxicology Mechanisms and Methods, 28(5), 386-396. https://doi.org/10.1080/15376516.2017.1414343
Jones, R. R., Fisher, J. A., Medgyesi, D. N., Buller, I. D., Liao, L. M., Gierach, G., Ward, M. H., & Silverman, D. T. (2023). Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a US cohort. Journal of the National Cancer Institute, 115(4), 405-412. https://doi.org/10.1093/jnci/djad004
Marsh, G. M., Keeton, K. A., Riordan, A. S., Best, E. A., & Benson, S. M. (2019). Ethylene oxide and risk of lympho-hematopoietic cancer and breast cancer: A systematic literature review and meta-analysis. International Archives of Occupational and Environmental Health, 92(7), 919-939. https://doi.org/10.1007/s00420-019-01438-z
Mikoczy, Z., Tinnerberg, H., Bjork, J., & Albin, M. (2011). Cancer incidence and mortality in Swedish sterilant workers exposed to ethylene oxide: Updated cohort study findings 1972-2006. International Journal of Environmental Research and Public Health, 8(6), 2009-2019. https://doi.org/10.3390/ijerph8062009
Steenland, K., Stayner, L., & Deddens, J. (2004). Mortality analyses in a cohort of 18 235 ethylene oxide exposed workers: Follow up extended from 1987 to 1998. Occupational and Environmental Medicine, 61(1), 2-7. https://doi.org/10.1136/oem.2003.009332
U.S. Environmental Protection Agency. (2016). Evaluation of the inhalation carcinogenicity of ethylene oxide (EPA/635/R-16/350Fa). National Center for Environmental Assessment. https://www.epa.gov/iris
U.S. Environmental Protection Agency. (2024). Ethylene oxide emissions standards for sterilization facilities: National emission standards for hazardous air pollutants. Federal Register. https://www.epa.gov/stationary-sources-air-pollution/ethylene-oxide-emissions-standards-sterilization-facilities